Neuroscience

Reunion Neuroscience Appoints Mark Pollack, M.D., as Chief Medical OfficerReunion Neuroscience Appoints Mark Pollack, M.D., as Chief Medical Officer

Reunion Neuroscience Appoints Mark Pollack, M.D., as Chief Medical Officer

MORRISTOWN, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment…

11 months ago
Neurophet-NTU Singapore, recognized for outstanding joint researchNeurophet-NTU Singapore, recognized for outstanding joint research

Neurophet-NTU Singapore, recognized for outstanding joint research

- Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis SEOUL, South Korea, Sept. 9, 2024…

11 months ago
Gladstone Institutes Launches Capital Campaign to Accelerate a Biomedical RevolutionGladstone Institutes Launches Capital Campaign to Accelerate a Biomedical Revolution

Gladstone Institutes Launches Capital Campaign to Accelerate a Biomedical Revolution

The $350 million Gladstone NOW campaign will raise funds to expand Gladstone's footprint, hire hundreds of additional scientists, and seize…

11 months ago
CORUNDUM SYSTEMS BIOLOGY APPOINTS JESSICA SCHNEIDER AS CHIEF SCIENTIFIC OFFICERCORUNDUM SYSTEMS BIOLOGY APPOINTS JESSICA SCHNEIDER AS CHIEF SCIENTIFIC OFFICER

CORUNDUM SYSTEMS BIOLOGY APPOINTS JESSICA SCHNEIDER AS CHIEF SCIENTIFIC OFFICER

Former Takeda Ventures Director Joins Investment Company to Spur Systems Biology Business Creation and Innovation TOKYO, Sept. 4, 2024 /PRNewswire/…

11 months ago
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials networkEmmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network

Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network

Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on…

11 months ago
Revolutionary Hypnotherapy Technique Emerges as the #1 Method to Quit Nicotine – Changing the Game in Behavioral HealthRevolutionary Hypnotherapy Technique Emerges as the #1 Method to Quit Nicotine – Changing the Game in Behavioral Health

Revolutionary Hypnotherapy Technique Emerges as the #1 Method to Quit Nicotine – Changing the Game in Behavioral Health

SAN FRANCISCO, CA / ACCESSWIRE / September 3, 2024 / In a groundbreaking development for those struggling with nicotine addiction,…

11 months ago
10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research

10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research

PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today…

11 months ago
INSIGHTEC APPOINTS INDUSTRY LEADER JAKE GHANNAM AS CHIEF COMMERCIAL OFFICERINSIGHTEC APPOINTS INDUSTRY LEADER JAKE GHANNAM AS CHIEF COMMERCIAL OFFICER

INSIGHTEC APPOINTS INDUSTRY LEADER JAKE GHANNAM AS CHIEF COMMERCIAL OFFICER

HAIFA, Israel and MIAMI, Sept. 3, 2024 /PRNewswire/ -- Insightec, a global healthcare company dedicated to using focused ultrasound to…

11 months ago
The nervous system’s matchmakerThe nervous system’s matchmaker

The nervous system’s matchmaker

COLD SPRING HARBOR, N.Y., Sept. 3, 2024 /PRNewswire/ -- When you ask a rideshare app to find you a car, the…

11 months ago
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful StoriesNeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

NeuroStar Is More Than Halfway to Achieving Its Five-Year Goal of Saving Thousands of LivesMALVERN, Pa., Sept. 03, 2024 (GLOBE…

11 months ago